GlassScriptPhysician profile
Gregory M Oldford
NPI 1376508762
$28,437.32
in general payments reported to CMS, 2019-2025
48 companies · $2,125 in 2025
The $2,125 reported for 2025 was more than what 81% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $3,596 · 2021: $1,053 · 2022: $1,239 · 2023: $1,527 · 2024: $1,684 · 2025: $2,125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,336.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,336.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $20,310.18 | 2019-2025 | Xtandi, Myrbetriq |
| Sumitomo Pharma America, INC. | $962.03 | 2023-2025 | Gemtesa, Orgovyx |
| Antares Pharma, INC. | $854.63 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Pfizer INC. | $702.21 | 2019-2025 | |
| Myriad Genetic Laboratories, INC. | $516.74 | 2021-2025 | Prolaris, Myrisk |
| Ferring Pharmaceuticals INC. | $415.80 | 2019-2025 | Adstiladrin |
| Abbvie INC. | $367.51 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $319.81 | 2022-2025 | Keytruda, Lynparza, Welireg |
| Teleflex LLC | $294.25 | 2021-2025 | Urolift |
| Laborie Medical Technologies Corp. | $272.23 | 2023-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Janssen Biotech, INC. | $255.97 | 2019-2025 | Erleada |
| Allergan, INC. | $233.20 | 2019-2022 | |
| Urovant Sciences INC | $203.97 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $192.67 | 2021-2025 | Lynparza |
| Dendreon Pharmaceuticals LLC | $177.40 | 2019-2025 | Provenge |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $177.14 | 2022-2025 | Itind System, Olympus, 4k Camera Head |
| Tolmar Pharmaceuticals, INC. | $172.76 | 2019-2022 | |
| Verity Pharmaceuticals INC. | $161.37 | 2024-2025 | Tlando |
| Novartis Pharmaceuticals Corporation | $152.58 | 2024-2025 | |
| Coloplast Corp | $148.29 | 2019-2023 | Porges Coloplast, Speedicath |
| Photocure INC | $119.74 | 2019-2025 | Cysview |
| 180 Medical, INC. | $106.71 | 2019-2023 | |
| Endo Pharmaceuticals INC. | $106.67 | 2019-2024 | Xiaflex |
| Medtronic, INC. | $106.21 | 2024-2025 | Interstim |
| Axonics, INC. | $101.11 | 2022-2023 | Axonics, Bulkamid |
| Halozyme INC | $93.91 | 2023 | |
| Urogen Pharma, INC. | $84.37 | 2023-2025 | Jelmyto |
| Caldera Medical, INC | $83.52 | 2023 | Desara |
| Blue Earth Diagnostics | $83.45 | 2019-2021 | |
| Endo USA, INC. | $82.84 | 2024-2025 | Xiaflex |
| Immunitybio, INC. | $73.87 | 2024-2025 | |
| Boston Scientific Corporation | $60.22 | 2019-2024 | Lithovue |
| Amgen INC. | $59.79 | 2019-2022 | |
| Calyxo, INC. | $59.74 | 2024-2025 | Cvac Aspiration System |
| Clarus Therapeutics INC. | $54.42 | 2021 | |
| Neotract INC. | $37.35 | 2019-2020 | |
| Mission Pharmacal Company | $29.62 | 2022 | |
| Zyla Life Sciences, INC. | $25.06 | 2019 | |
| Accord Healthcare, INC. | $24.46 | 2024 | |
| Progenics Pharmaceuticals, INC. | $24.17 | 2024 | |
| Myovant Sciences INC. | $22.94 | 2021 | |
| Azurity Pharmaceuticals, INC. | $20.47 | 2025 | Azmiro |
| Sun Pharmaceutical Industries INC. | $16.51 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.14 | 2019 | |
| Angiodynamics, INC. | $14.30 | 2024 | Nanoknife |
| Avation Medical, INC. | $13.96 | 2025 | Vivally System |
| Cook Medical LLC | $13.53 | 2019 | |
| Acerus Pharmaceuticals Corporation | $12.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Oldford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.